Results 81 to 90 of about 189 (142)

Effectiveness of enzyme replacement therapy in Fabry disease: Long term experience in Argentina. [PDF]

Mol Genet Metab Rep, 2017
Cabrera G, Politei J, Antongiovani N, Amartino H, GADYTEF (Grupo Argentino de Diagnóstico y Tratamiento de la Enfermedad de Fabry).   +4 more
europepmc   +1 more source

Nefropatía por enfermedad de Fabry

Nefrología, 2011
openaire   +1 more source

Enfermedad de Fabry: espectro clínico de los angioqueratomas

Actas Dermo-Sifiliográficas, 2013
R.M. Guinovart, I. Bielsa, G. Pintos-Morell, C. Ferrándiz   +3 more
openaire   +1 more source

Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher's disease. [PDF]

J Orthop Surg Res, 2019
Roca-Espiau M, Andrade-Campos M, Cebolla JJ, López de Frutos L, Medrano-Engay B, López-Royo MP, Giraldo P.   +6 more
europepmc   +1 more source

Enfermedad de Fabry - revisión general

Medwave, 2004
openaire   +1 more source

Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. [PDF]

Circulation, 2023
Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Virani SS, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Martin SS, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.   +43 more
europepmc   +1 more source

Enzyme replacement therapy in infants and very young children with Gaucher disease using velaglucerase alfa: a single-center experience. [PDF]

Front Pediatr
Goker-Alpan O, Ivanova MM, Pathak R, Wright E.   +3 more
europepmc   +1 more source

[Identification of occupational risks associated with diseases suspected to be of possible occupational origin seen in the National Health System]. [PDF]

Aten Primaria, 2012
Delclòs J, Alarcón M, Casanovas A, Serra C, Fernández R, de Peray JL, Benavides FG.   +6 more
europepmc   +1 more source

Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases. [PDF]

Front Pharmacol, 2019
Morgado-Pascual JL, Rayego-Mateos S, Tejedor L, Suarez-Alvarez B, Ruiz-Ortega M.   +4 more
europepmc   +1 more source